Literature DB >> 9317035

Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent.

C Cywes1, H C Hoppe, M Daffé, M R Ehlers.   

Abstract

The choice of host cell receptor and the mechanism of binding (opsonic versus nonopsonic) may influence the intracellular fate of Mycobacterium tuberculosis. We have identified two substrains of M. tuberculosis H37Rv, designated H37Rv-CC and -HH, that differed in their modes of binding to complement receptor type 3 (CR3) expressed in transfected Chinese hamster ovary (CHO-Mac-1) cells: H37Rv-CC bound nonopsonically, whereas H37Rv-HH bound only after opsonization in fresh serum. H37Rv-CC also bound nonopsonically to untransfected CHO cells, whereas H37Rv-HH binding was enhanced by serum and was mediated by the 1D1 antigen, a bacterial adhesin previously identified as a polar phosphatidylinositol mannoside. H37Rv-CC and -HH had identical IS6110 DNA fingerprint patterns. Of five M. tuberculosis clinical isolates examined, four displayed the same binding phenotype as H37Rv-CC, as did the Erdman strain, whereas one isolate, as well as Mycobacterium smegmatis, behaved like H37Rv-HH. Nonopsonic binding of H37Rv-CC to CHO cell-expressed CR3 was apparently to the beta-glucan lectin site, as it was cation independent and inhibited by laminarin (seaweed beta-glucan) and N-acetylglucosamine; laminarin also inhibited the binding of H37Rv-CC to monocyte-derived macrophages. Further, binding of H37Rv-CC to CHO-Mac-1 cells was inhibited by prior agitation of bacteria with glass beads (which strips outer capsular polysaccharides) and by preincubation with amyloglucosidase, as well as by the presence of capsular D-glucan and D-mannan from M. tuberculosis Erdman, but not by Erdman D-arabino-D-mannan, yeast mannan, or capsular components from H37Rv-HH. Analysis of capsular carbohydrates revealed that H37Rv-CC expressed 5-fold more glucose and 2.5-fold more arabinose and mannose than H37Rv-HH. Flow cytometric detection of surface epitopes indicated that H37Rv-CC displayed twofold less surface-exposed phosphatidylinositol mannoside and bound complement C3 less efficiently than H37Rv-HH; these differences were eliminated after treatment of H37Rv-CC with glass beads. Thus, outer capsular polysaccharides mediate the binding of H37Rv-CC to CR3, likely to the beta-glucan site. Moreover, there are strain-dependent differences in the thickness or composition of capsular polysaccharides that determine the mode of binding of M. tuberculosis to mammalian cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317035      PMCID: PMC175611          DOI: 10.1128/iai.65.10.4258-4266.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  33 in total

Review 1.  Mannose-binding lectin: the pluripotent molecule of the innate immune system.

Authors:  M W Turner
Journal:  Immunol Today       Date:  1996-11

2.  Identification of phosphatidylinositol mannoside as a mycobacterial adhesin mediating both direct and opsonic binding to nonphagocytic mammalian cells.

Authors:  H C Hoppe; B J de Wet; C Cywes; M Daffé; M R Ehlers
Journal:  Infect Immun       Date:  1997-09       Impact factor: 3.441

3.  Nonopsonic binding of Mycobacterium tuberculosis to human complement receptor type 3 expressed in Chinese hamster ovary cells.

Authors:  C Cywes; N L Godenir; H C Hoppe; R R Scholle; L M Steyn; R E Kirsch; M R Ehlers
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  Structural features of the exocellular polysaccharides of Mycobacterium tuberculosis.

Authors:  A Lemassu; M Daffé
Journal:  Biochem J       Date:  1994-01-15       Impact factor: 3.857

5.  Molecular composition of the outermost capsular material of the tubercle bacillus.

Authors:  A Ortalo-Magné; M A Dupont; A Lemassu; A B Andersen; P Gounon; M Daffé
Journal:  Microbiology       Date:  1995-07       Impact factor: 2.777

6.  Comparison of various repetitive DNA elements as genetic markers for strain differentiation and epidemiology of Mycobacterium tuberculosis.

Authors:  D van Soolingen; P E de Haas; P W Hermans; P M Groenen; J D van Embden
Journal:  J Clin Microbiol       Date:  1993-08       Impact factor: 5.948

7.  Mycobacteria-macrophage interactions. Macrophage phenotype determines the nonopsonic binding of Mycobacterium tuberculosis to murine macrophages.

Authors:  R W Stokes; I D Haidl; W A Jefferies; D P Speert
Journal:  J Immunol       Date:  1993-12-15       Impact factor: 5.422

8.  Identification of macrophage and stress-induced proteins of Mycobacterium tuberculosis.

Authors:  B Y Lee; M A Horwitz
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

9.  Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages.

Authors:  C S Hirsch; J J Ellner; D G Russell; E A Rich
Journal:  J Immunol       Date:  1994-01-15       Impact factor: 5.422

10.  Ingestion of acapsular Cryptococcus neoformans occurs via mannose and beta-glucan receptors, resulting in cytokine production and increased phagocytosis of the encapsulated form.

Authors:  C E Cross; G J Bancroft
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

View more
  43 in total

Review 1.  Phagosome maturation: a few bugs in the system.

Authors:  C C Scott; R J Botelho; S Grinstein
Journal:  J Membr Biol       Date:  2003-06-01       Impact factor: 1.843

2.  Capsular glucan and intracellular glycogen of Mycobacterium tuberculosis: biosynthesis and impact on the persistence in mice.

Authors:  Tounkang Sambou; Premkumar Dinadayala; Gustavo Stadthagen; Nathalie Barilone; Yann Bordat; Patricia Constant; Florence Levillain; Olivier Neyrolles; Brigitte Gicquel; Anne Lemassu; Mamadou Daffé; Mary Jackson
Journal:  Mol Microbiol       Date:  2008-09-18       Impact factor: 3.501

Review 3.  Macrophage receptors for Mycobacterium tuberculosis.

Authors:  J D Ernst
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

4.  Crystal structure of full-length Mycobacterium tuberculosis H37Rv glycogen branching enzyme: insights of N-terminal beta-sandwich in substrate specificity and enzymatic activity.

Authors:  Kuntal Pal; Shiva Kumar; Shikha Sharma; Saurabh Kumar Garg; Mohammad Suhail Alam; H Eric Xu; Pushpa Agrawal; Kunchithapadam Swaminathan
Journal:  J Biol Chem       Date:  2010-05-05       Impact factor: 5.157

5.  Activation of human neutrophils by mycobacterial phenolic glycolipids.

Authors:  J Fäldt; C Dahlgren; A Karlsson; A M Ahmed; D E Minnikin; M Ridell
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

Review 6.  Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis.

Authors:  Joanne Turner; Jordi B Torrelles
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

7.  Genetics of Capsular Polysaccharides and Cell Envelope (Glyco)lipids.

Authors:  Mamadou Daffé; Dean C Crick; Mary Jackson
Journal:  Microbiol Spectr       Date:  2014

8.  The glycan-rich outer layer of the cell wall of Mycobacterium tuberculosis acts as an antiphagocytic capsule limiting the association of the bacterium with macrophages.

Authors:  Richard W Stokes; Raymond Norris-Jones; Donald E Brooks; Terry J Beveridge; Dan Doxsee; Lisa M Thorson
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

9.  Direct visualization by cryo-EM of the mycobacterial capsular layer: a labile structure containing ESX-1-secreted proteins.

Authors:  Musa Sani; Edith N G Houben; Jeroen Geurtsen; Jason Pierson; Karin de Punder; Maaike van Zon; Brigitte Wever; Sander R Piersma; Connie R Jiménez; Mamadou Daffé; Ben J Appelmelk; Wilbert Bitter; Nicole van der Wel; Peter J Peters
Journal:  PLoS Pathog       Date:  2010-03-05       Impact factor: 6.823

10.  Redox biology of Mycobacterium tuberculosis H37Rv: protein-protein interaction between GlgB and WhiB1 involves exchange of thiol-disulfide.

Authors:  Saurabh Garg; Md Suhail Alam; Richa Bajpai; Kv Radha Kishan; Pushpa Agrawal
Journal:  BMC Biochem       Date:  2009-01-05       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.